
Patients who receive either Pfizer or GSK’s respiratory syncytial virus vaccine may be at increased risk of Guillain-Barré syndrome.

Patients who receive either Pfizer or GSK’s respiratory syncytial virus vaccine may be at increased risk of Guillain-Barré syndrome.

Six months after the announcement of McKesson Amplify in June, the initiative has secured funding across all 50 states in the US.

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed the benefits of tirzepatide compared with semaglutide.

The individual who first reported severe bird flu and hospitalization has since succumbed to their illness.

David Nau, PhD, discusses how more graduating pharmacy students say they would choose pharmacy again if starting college over.

Researchers compared simultaneous and sequential administration of the mRNA COVID-19 and inactivated influenza vaccines.

Rebecca Lahrman, PharmD, MS, BCACP, discusses her experience taking medical students for rotations in a community pharmacy.

US News & World Report nutrition experts detailed the best types of diets for maintaining patient health in 2025.

A study found that of 110 patients with long COVID, over half reported decreased QOL due to pain, discomfort, anxiety, or depression.

PQA Health Equity Technical Expert Panel recommendations inform measure testing, use in quality programs, and risk adjustment models

Using the DASH Rapid PCR System, providers can yield test results in under 1 minute of hands-on time.

A study found that sending a letter to providers about standards of care and glucagon preparations could increase glucagon prescription rates.

Researchers explored ideas of simplifying the vaccination process to yield higher rates of adult immunization, similar to that of the COVID-19 pandemic.

Researchers aimed to identify the barriers impeding HPV vaccine uptake since 2019 among US mid-adults aged 27 to 45.

Jennifer Goldman, PharmD, CDCES, BC-ADM, discusses how putting glucagon kits in public areas and long-term care facilities can help patients with diabetes.

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses the benefits of glucagon and why pharmacists should be able to prescribe it.

XG005 from Xgene Pharmaceutical is a novel, non-opioid chemical entity that targets anti-nociceptive and anti-neuropathic pain pathways.

Check out this list of our top 5 most read immunization stories from the year 2024.

Check out this list of our top 5 most read nonopioid pain management stories from the year 2024.

Check out this list of our top 5 most read obesity stories from the year 2024.

Check out this list of our top 5 most read diabetes stories from the year 2024.

Check out this list of our top 5 most read women’s health stories from the year 2024.

Check out this list of our top 5 most read infectious disease stories from the year 2024.

Check out this list of our top 5 most read pain management stories from the year 2024.

Check out this list of our top 5 most read cardiology stories from the year 2024.

Check out this list of our top 5 most read digestive health stories from the year 2024.

Check out this list of our top 5 most read Total Pharmacy stories from the year 2024.

Check out this list of our top 5 most read COVID-19 stories from the year 2024.

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences, discuses the benefits of glucagon.

Check out this list of our top 5 most read Drug Topics stories from the year 2024.